Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nandini Menon

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Oral Oncology|July 6, 2023
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre studySaswata Saha, Vijay M Patil, Vanita Noronha, et al.
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 27, 2021
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settingsAkhil Kapoor, Vanita Noronha, Amit Joshi, et al.
Ecancermedicalscience|March 8, 2021
Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastomaGunjesh Kumar, Hollis DSouza, Nandini Menon, et al.
South Asian Journal of Cancer|December 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from IndiaAjaykumar Singh, Vanita Noronha, Vijay Patil, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Gene|November 2, 2023
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapyJanani Sambath, Vanita Noronha, Srikanth S Manda, et al.
Ecancermedicalscience|March 5, 2024
Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in IndiaVanita Noronha, Laboni Sarkar, Vijay Patil, et al.
Cancers|March 28, 2024
Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT ImagingAbhishek Mahajan, Vatsal Kania, Ujjwal Agarwal, et al.
Ecancermedicalscience|April 28, 2023
Management of testicular tumours in patients with undescended testes- a challenging but rewarding task: experience from a tertiary care cancer centre in IndiaArnav Tongaonkar, Vijai Simha, Nandini Menon, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Oral Oncology|July 6, 2023
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre studySaswata Saha, Vijay M Patil, Vanita Noronha, et al.
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 27, 2021
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settingsAkhil Kapoor, Vanita Noronha, Amit Joshi, et al.
Ecancermedicalscience|March 8, 2021
Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastomaGunjesh Kumar, Hollis DSouza, Nandini Menon, et al.
South Asian Journal of Cancer|December 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from IndiaAjaykumar Singh, Vanita Noronha, Vijay Patil, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Gene|November 2, 2023
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapyJanani Sambath, Vanita Noronha, Srikanth S Manda, et al.
Ecancermedicalscience|March 5, 2024
Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in IndiaVanita Noronha, Laboni Sarkar, Vijay Patil, et al.
Cancers|March 28, 2024
Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT ImagingAbhishek Mahajan, Vatsal Kania, Ujjwal Agarwal, et al.
Ecancermedicalscience|April 28, 2023
Management of testicular tumours in patients with undescended testes- a challenging but rewarding task: experience from a tertiary care cancer centre in IndiaArnav Tongaonkar, Vijai Simha, Nandini Menon, et al.
Pageof 17